Where does Michael Melnick work?

Michael Melnick is at Baruch Future Ventures.

What does Michael Melnick invest in?

Michael Melnick invests in Biotech, Cleantech.

Where did Michael Melnick go to school?

Michael Melnick studied at Harvard University (PhD, Genetics); Stanford University (BS with honors, MS); The College Preparatory School.

Michael Melnick

Investor

Investor at Baruch Future Ventures

San Diego, California, United States

Find your path to Michael

34 people in our graph can introduce you to Michael.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jennifer Stacey to introduce you to Michael

You →Jennifer · together at Cell Signaling Technology (2000–2006) →Michael

Ask Jamie Chen to introduce you to Michael

You →Jamie · 2 people · together at BioAtla →Michael

Ask Sam Okafor to introduce you to Michael

You →Sam · together at New England Biolabs →Michael

Your email: the people you already email who know Michael
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Michael
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Michael Melnick is a biotech scientist, investor, and entrepreneur. He began his career as a staff scientist at New England Biolabs, co-founded the cancer research and diagnostics company Cell Signaling Technology (serving as VP of Business and Corporate Development), and worked as a Venture Partner at CMEA Capital, where he invested in life science, industrial biotech, and cleantech. He has held operating roles at various biotech companies, most recently BioAtla, and holds a B.S. and M.S. in Biological Sciences from Stanford University and a Ph.D. in Genetics from Harvard University.

Invests in

BiotechCleantech

Experience

BioAtla, Inc.VP CMCcurrent2014 — presentSan Diego
CMEA CapitalVenture Partner2008 — 2014San Francisco Bay Area
Assay Designs (acquired by Enzo Biochem)Executive Vice President2006 — 2007
Cell Signaling TechnologyVP Business and Corporate Development1999 — 2006
New England BiolabsStaff Scientist1995 — 1999

Skills & more

CMCBiotechnologyLifesciencesMolecular Biology21Drug Discovery20Technology Transfer48R&D17Immunology5Patents7Commercialization31Entrepreneurship8Venture Capital54

+6 more

Start-upsBiopharmaceuticalsCorporate DevelopmentDue DiligencePharmaceutical IndustryPrivate Equity

From Michael's professional profile.

Colleagues at Baruch Future Ventures

Ethan Mirsky

Investor at Baruch Future Ventures

Gjalt Huisman

Investor at Baruch Future Ventures

Jeff Roberts

Investor at Baruch Future Ventures

Josh Silverman

Investor at Baruch Future Ventures

Miranda Tzab

Investor at Baruch Future Ventures

Tom Baruch

Investor at Baruch Future Ventures

Frequently asked questions

Who is Michael Melnick?: Michael Melnick is a biotech scientist, investor, and entrepreneur. He began his career as a staff scientist at New England Biolabs, co-founded the cancer research and diagnostics company Cell Signaling Technology (serving as VP of Business and Corporate Development), and worked as a Venture Partner at CMEA Capital, where he invested in life science, industrial biotech, and cleantech. He has held operating roles at various biotech companies, most recently BioAtla, and holds a B.S. and M.S. in Biological Sciences from Stanford University and a Ph.D. in Genetics from Harvard University.
Where does Michael Melnick work?: Michael Melnick is at Baruch Future Ventures.
What does Michael Melnick invest in?: Michael Melnick invests in Biotech, Cleantech.
Where did Michael Melnick go to school?: Michael Melnick studied at Harvard University (PhD, Genetics); Stanford University (BS with honors, MS); The College Preparatory School.